本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Intra-Cellular Therapies Inc.

131.87
+0.0000
成交量:- -
成交額:- -
市值:140.21億
市盈率:-182.12
高:131.87
開:131.87
低:131.87
收:131.87
資料載入中...
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/05

重要事件披露

Form 8-K - Current report
2024/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/10

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/06/25

SEC問詢函

Form CORRESP - Correspondence
2024/06/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans